← Browse by Condition
Medical Condition
leptomeningeal metastasis
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2, Phase 1, Phase 2
NCT06643000
Recruiting
Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis
Enrollment
60 pts
Location
China
Sponsor
Henan Cancer Hospital
NCT06296745 Phase 2
Recruiting
Intrathecal Pemetrexed for Leptomeningeal Metastasis From Lung Adenocarcinoma That Progressed After Osimertinib.
Enrollment
36 pts
Location
China
Sponsor
Guangzhou Medical University
NCT06809530 Phase 1, Phase 2
Recruiting
Intrathecal Dual Checkpoint Inhibitor (PD-1 and CTLA-4) in Combination With Pemetrexed for Leptomeningeal Metastasis
Enrollment
34 pts
Location
China
Sponsor
Guangzhou Medical University
NCT05805631 Phase 2
Recruiting
Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC
Enrollment
23 pts
Location
Taiwan
Sponsor
Taipei Veterans General Hospit...